Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Share News (BXP)

Share Price Information for Beximco Pharma (BXP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.128%)
Open: 40.00
High: 40.00
Low: 40.00
Prev. Close: 40.00
BXP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Cohort wins Italian navy contract; Beximco waits

Wed, 07th Jul 2021 22:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

-----------

PureTech Health PLC - Boston, Massachusetts-based biotherapeutics - Signs clinical trial and supply agreement with an affiliate of BeiGene Ltd to evaluate BeiGene's tislelizumab, an anti-PD-1 immune checkpoint inhibitor, in combination with PureTech's LYT-200, an investigational monoclonal antibody targeting galectin-9, for the potential treatment of difficult-to-treat solid tumour indications that are associated with poor survival rates. "We believe LYT-200 has the potential to engage the immune system against what are currently intractable cancers, both as a single agent and in combination with checkpoint inhibitors. We look forward to evaluating whether LYT-200 in combination with BeiGene's tislelizumab can improve outcomes for patients with metastatic solid tumours," PureTech Head of Oncology Aleksandra Filipovic says.

-----------

Wincanton PLC - Wiltshire-based logistics firm - Confirms that strong revenue performance recorded in the second half of the prior year has continued into the first quarter of new financial year, with "sustained growth and an attractive pipeline of opportunities" in each of the company's four sectors. "Wincanton continues to make operational and strategic progress and it is trading in line with expectations. Profits are up significantly on the same period last year," company adds.

-----------

Seeing Machines Ltd - Canberra-based driver-monitoring technology company - Signs agreement with Airservices Australia to integrate company's technology into the air traffic control environment. The initial program of work is valued at around AUD250,000, about USD187,000. "The company work with Airservices to jointly pursue the development and integration of head, eye and face tracking and the related high-level signals including; workload, fatigue and attention to support and optimize safe and effective controller performance in an increasingly automated air traffic control environment," company says.

-----------

Somero Enterprises Inc - Fort Myers, Florida-based concrete levelling equipment company - Expects to beat previous 2021 guidance due to ending first half with stronger than anticipated trading in the US and momentum continuing into second half. Now expects 2021 revenue to be around USD110.0 million and adjusted earnings before interest, tax, depreciation and amortisation around USD35.0 million, previously seen at USD100.0 million and USD31.0 million respectively.

-----------

Cohort PLC - defence and security markets-focussed technology company - Wholly owned subsidiary Elac Sona GmbH wins EUR49 million order from Leonardo SpA, sonar systems for two new U212 Near Future Submarines being supplied by Fincantieri for the Italian Navy. The contract also includes delivery of special test and training tools and associated technical services. Work on the contract will commence immediately and will complete in 2030.

-----------

K3 Capital Group PLC - Bolton, England-based advisory services provider - To buy M&A advisory firm Knight Corp Finance Group Ltd and research and development tax advisory firm Knight R&D Ltd. Plans placing to raise GBP10.0 million to pay for two acquisitions. Will place 2.9 million shares at 340 pence each. "The acquisitions are in line with K3's strategy to acquire complementary and value accretive businesses to build out its existing SME focussed service lines. The proceeds of the placing will be used in part to fund the acquisitions and to satisfy an element of fees payable in relation to the placing and the acquisitions," company says.

-----------

7digital Group PLC - London-based music licensing provider - Signs 24-month contracts with two new clients: Barry's fitness brand, and Volava, a European interactive fitness platform. "The companies will use 7digital's music platform-as-a-service to power their services in the fitness industry, a strategic growth market for 7digital. Both contracts, signed with Barry's Bootcamp Holdings, LLC, and Volava SL, respectively, commence immediately and consist of an upfront set-up fee as well as recurring monthly revenues," company adds.

-----------

Beximco Pharmaceuticals Ltd - Bangladesh-based generic pharmaceutical products and active pharmaceutical ingredients maker - Notes Serum Institute of India unable to supply any further vaccine doses to Bangladesh beyond the seven million doses that had already supplied to Bangladesh during January and February 2021, due to Indian government's controls on vaccine exports. "Beximco Pharma's original agreement with SII and GOB remains valid until June 14, 2022 and all parties anticipate that SII will be able to re-commence exports to Bangladesh once the temporary export controls from India have been relaxed when, as previously announced, the company will collaborate with SII to provide a revised supply schedule for GOB," company adds.

-----------

Coro Energy PLC - South East Asian energy company - Notes 20%-owned subsidiary on Ventures Holdings Ltd signs new partnership with GLIL Infrastructure Fund LLP for ion Ventures' portfolio of grid scale energy storage projects in the UK. "Pursuant to the partnership, GLIL has committed up to GBP150 million of capital to a newly incorporated vehicle, Flexion Energy Holdings UK Ltd, with ion Ventures transferring its existing portfolio of UK grid scale energy storage projects into Flexion, as well as all of its future business associated with the development of UK grid scale energy storage assets," company explains.

-----------

Starcom PLC - remote tracking systems firm, headquartered in Jersey - Wins smart guard innovation challenge for its Lokies keyless padlock at recent DHL Logistics & Supply Chain Summit. "This has led to the initiation of a trial of Lokies by DHL in one of its main global hubs in Singapore to examine all aspects of the product, both technical and commercial, with a view to DHL potentially trialing the Lokies smart padlock with some of its customers," company explains. Adds: "At this stage there is no commitment from or contract with DHL, or significant revenue from the trial, and the duration of the trial is unknown."

-----------

Catenae Innovation PLC - London-based data management services provider - Subsidiary Hyperneph Software Ltd develops cloud-based platform and mobile app that is being used with a charity working in conjunction with public sector organisations. The agreement is for a period of up to 12 months and is currently on trial in a major UK city. "The mobile app enables Hyperneph's customer to introduce an individual to a service provider and subsequently tracks the progress of their initial engagement, whilst respecting the privacy and rights of the person under the UK's GDPR legislation," company explains. Initial contract value is GBP12,500. "If the project is successful it could be rolled out on a wider scale across the UK, with the potential to generate recurring income for the group," company adds. Hyperneph is 51%-owned by Catenae.

-----------

Tiger Royalties & Investments PLC - London-based royalties and proactive investments group - Says net asset value per share ends second quarter at 0.30 pence versus 0.23p at March 31.

-----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Jul 2018 12:53

Monday broker round-up

(Sharecast News) - Hargreaves Lansdown: Jefferies downgrades to underperform with a target price of 1,650p.

Read more
27 Jan 2017 10:45

Beximco profits rise as it begins US exports

(ShareCast News) - Bangladeshi generic pharmaceutical products and active pharmaceutical ingredients manufacturer Beximco Pharmaceuticals announced its unaudited financial results for the six months to 31 December on Friday. The AIM-traded company said net sales increased by 13.6% to BDT 7,630.6m or

Read more
25 Jan 2017 16:10

Beximco Pharma partners with BioCare in Malaysia

(ShareCast News) - Generic pharmaceutical products manufacturer Beximco Pharmaceuticals announced the creation of a joint venture with BioCare Manufacturing, based in Malaysia, as the company's first overseas manufacturing collaboration on Wednesday. The AIM-traded firm said that under the terms of

Read more
21 Nov 2016 10:49

Beximco Pharmaceuticals Highlights Continued Progress

Read more
25 Oct 2016 07:07

Beximco Gets US Approval For Generic Cardiovascular Drug Sotalol

Read more
20 Oct 2016 11:01

Beximco sales grow in first half

(ShareCast News) - Generic pharmaceutical products and active ingredients manufacturer Beximco Pharmaceuticals posted audited results for the half year to 30 June on Thursday, with net sales growing by 13.1% to BDT 7.07bn. The AIM-traded firm's export sales grew by 5.3%, and domestic market sales in

Read more
5 Aug 2016 07:21

Beximco Commences Export Of Carvedilol Hypertension Drug To US

Read more
17 Jun 2016 15:21

Beximco makes historic drug shipment to Kuwait

(ShareCast News) - Generic pharmaceutical manufacturer Beximco announced on Friday that it has commenced the export of pharmaceuticals to Kuwait. The AIM-traded firm said it marks the first time a Bangladeshi pharmaceutical company has launched products in any Gulf member country under the Gulf Coop

Read more
17 Jun 2016 07:21

Beximco Starts Export Of Pharmaceutical Products To Kuwait

Read more
9 May 2016 07:52

Beximco Pharmaceuticals Profit Grows As It Expands Geographically

Read more
6 May 2016 08:02

Beximco Postpones Annual Meeting After Change Of Financial Year

Read more
19 Nov 2015 09:02

Beximco Pharmaceuticals Gets US Approval For Carvedilol Manufacturing

Read more
24 Jul 2015 08:32

Beximco Confident In Meeting Targets As First-Half Profit Rises

Read more
24 Jun 2015 06:53

Beximco Pharmaceuticals Gets Approval From US Authorities

Read more
15 Jun 2015 08:07

Beximco Pharmaceuticals Feels Political Turmoil But Sees Recovery

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.